Literature DB >> 35738514

Development of multiple cutaneous immune-related adverse events among cancer patients after immune checkpoint blockade.

Maria S Asdourian1, Nishi Shah2, Ted V Jacoby3, Yevgeniy R Semenov1, Tracey Otto4, Leah L Thompson1, Edward Christopher Dee5, Kerry L Reynolds6, Steven T Chen7.   

Abstract

Entities:  

Year:  2022        PMID: 35738514     DOI: 10.1016/j.jaad.2022.06.030

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   15.487


× No keyword cloud information.
  1 in total

1.  TIMM13 as a prognostic biomarker and associated with immune infiltration in skin cutaneous melanoma (SKCM).

Authors:  Sitong Zhou; Yuanyuan Han; Ronghua Yang; Xiaobing Pi; Jiehua Li
Journal:  Front Surg       Date:  2022-08-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.